SEC Form 4 · accession 0001209191-15-079682
PharMerica CORP · PMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Lindemoen
Officer — SVP Sales and Client Services
Period of report
Nov 11, 2015
Accepted (ET)
Nov 12, 2015 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388195
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par valueF1 | Nov 11, 2015 | S | 3,790 | $34.7071 | D | 18,009 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average purchase price for the transactions reported on this line. The range of prices for the transactions reported on this line was $34.70 to $34.751, inclusive. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.